Vienna University. Austria: 40 percent of people in the EU suffer from non-alcoholic
steatohepatitis (fatty liver disease), a disease which is becoming
increasingly more frequent as a result of diabetes and excess weight in
an affluent society. Currently, it is not possible to forecast the
further course of the disease – right up to cirrhosis and cancer of the
liver. Furthermore, an increased risk of heart attack and kidney damage
exists. In future, this should become possible using a Risk Score with
different biomarkers.